Abstract
Purpose
To provide treatment guidelines for patients with long bone metastatic disease based on a systematic review of the literature and to propose an algorithm to guide orthopedic surgeons in decision-making for these patients.
Materials and methods
We performed a computerized literature search in MEDLINE, EMBASE and Scopus for studies on patients with long bone metastases. We used the key words “long bones”, “metastasis” and “treatment” for published studies that evaluated any treatment for long bone metastases. The articles found were then studied to determine the accuracy of surgical treatments for long bone metastases in every anatomic location, regardless of cancer type, stage and grade of the oncologic disease. Guidelines inferred from this literature review were collected, and an algorithm was proposed.
Results
There was no clear evidence to support excision of a long bone metastatic lesion at the same surgical setting with internal fixation or prosthetic reconstruction. However, en bloc resection of an isolated bone metastasis may have a beneficial effect on survival. The life expectancy of the patients should be considered for any surgical treatment. Internal fixation preferably with reconstruction nails is indicated for meta-diaphyseal lesions; their rate of mechanical failure and complications ranges from 2 to 22 %. Prosthetic reconstruction is indicated for extensive lytic lesions or pathologic fractures in a meta-epiphyseal locations; their rate of mechanical failure and complications ranges from 3.7 to 35 %. Most of the internal fixation-related complications occur more than 1 year after treatment, in contrast to prosthetic reconstruction-related complications that may occur earlier.
Conclusions
Intramedullary nail fixation or prosthetic reconstruction should be chosen on the basis of the location of the lesion, the extent of bone destruction and the stability of the construct to outlast the expected life of the patient. Implant-related complication is similar but may occur earlier with prosthetic reconstructions.
Similar content being viewed by others
References
Cheung FH (2014) The practicing orthopedic surgeon’s guide to managing long bone metastases. Orthop Clin North Am 45:109–119
Weber KL, Randall RL, Grossman S, Parvizi J (2006) Management of lower-extremity bone metastasis. J Bone Jt Surg Am 88(Suppl 4):11–19
Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s–6249s
Schulman KL, Kohles J (2007) Economic burden of metastatic bone disease in the US. Cancer 109:2334–2342
Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH (2011) Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network. PLoS One 6:e19956
Ratasvuori M, Wedin R, Hansen BH, Keller J, Trovik C, Zaikova O et al (2014) Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. J Surg Oncol 110:360–365
Harvey N, Ahlmann ER, Allison DC, Wang L, Menendez LR (2012) Endoprostheses last longer than intramedullary devices in proximal femur metastases. Clin Orthop Relat Res 470:684–691
Wedin R, Bauer HCF (2005) Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Jt Surg Br 87:1653–1657
Ward WG, Holsenbeck S, Dorey FJ, Spang J, Howe D (2003) Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res 415(Suppl):S230–S244
Hunt KJ, Gollogly S, Randall RL (2006) Surgical fixation of pathologic fractures: an evaluation of evolving treatment methods. Bull Hosp Jt Dis 63(3–4):77–82
van Doorn R, Stapert JW (2000) Treatment of impending and actual pathological femoral fractures with the long Gamma nail in The Netherlands. Eur J Surg Acta Chir 166:247–254
Ruggieri P, Mavrogenis AF, Casadei R, Errani C, Angelini A, Calabrò T, Pala E, Mercuri M (2010) Protocol of surgical treatment of long bone pathological fractures. Injury 41(11):1161–1167
Facchini G, Di Tullio P, Battaglia M, Bartalena T, Tetta C, Errani C, Mavrogenis AF, Rossi G (2016) Palliative embolization for metastases of the spine. Eur J Orthop Surg Traumatol 26(3):247–252
Rossi G, Mavrogenis AF, Casadei R, Bianchi G, Romagnoli C, Rimondi E, Ruggieri P (2013) Embolisation of bone metastases from renal cancer. Radiol Med 118(2):291–302
Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ (2005) Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 23(25):6072–6082
Mirels H (1989) Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 249:256–264
Fottner A, Szalantzy M, Wirthmann L, Stähler M, Baur-Melnyk A, Jansson V et al (2010) Bone metastases from renal cell carcinoma: patient survival after surgical treatment. BMC Musculoskelet Disord 11:145
Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu S-M, Tannir NM et al (2007) Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Jt Surg Am 89:1794–1801
Evenski A, Ramasunder S, Fox W, Mounasamy V, Temple HT (2012) Treatment and survival of osseous renal cell carcinoma metastases. J Surg Oncol 106:850–855
Ruggieri P, Mavrogenis AF, Angelini A, Mercuri M (2011) Metastases of the pelvis: does resection improve survival? Orthopedics 34(7):e236–e244
Steensma M, Boland PJ, Morris CD, Athanasian E, Healey JH (2012) Endoprosthetic treatment is more durable for pathologic proximal femur fractures. Clin Orthop Relat Res 470:920–926
Van der Linden YM, Dijkstra PDS, Kroon HM, Lok JJ, Noordijk EM, Leer JWH et al (2004) Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Jt Surg Br 86:566–573
Cannon CP, Mirza AN, Lin PP, Lewis VO, Yasko AW (2008) Proximal femoral endoprosthesis for the treatment of metastatic. Orthopedics 31:361
Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L (2009) Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Jt Surg Br 91:108–112
Selek H, Başarir K, Yildiz Y, Sağlik Y (2008) Cemented endoprosthetic replacement for metastatic bone disease in the proximal femur. J Arthroplasty 23:112–117
Park DH, Jaiswal PK, Al-Hakim W, Aston WJS, Pollock RC, Skinner JA et al (2007) The use of massive endoprostheses for the treatment of bone metastases. Sarcoma 2007:62151
Nilsson J, Gustafson P (2008) Surgery for metastatic lesions of the femur: good outcome after 245 operations in 216 patients. Injury 39(4):404–410
Wedin R, Hansen BH, Laitinen M, Trovik C, Zaikova O, Bergh P, Kalén A, Schwarz-Lausten G, Vult von Steyern F, Walloe A, Keller J, Weiss RJ (2012) Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg 21(8):1049–1055
Scotti C, Camnasio F, Peretti GM, Fontana F, Fraschini G (2008) Modular prostheses in the treatment of proximal humerus metastases: review of 40 cases. J Orthop Traumatol 9(1):5–10
Miller BJ, Soni EE, Gibbs CP, Scarborough MT (2011) Intramedullary nails for long bone metastases: why do they fail? Orthopedics 34(4):274
Potter BK, Chow VE, Adams SC, Letson GD, Temple HT (2009) Endoprosthetic proximal femur replacement: metastatic versus primary tumors. Surg Oncol 18(4):343–349
Weiss RJ, Ekström W, Hansen BH, Keller J, Laitinen M, Trovik C, Zaikova O, Wedin R (2013) Pathological subtrochanteric fractures in 194 patients: a comparison of outcome after surgical treatment of pathological and non-pathological fractures. J Surg Oncol 107(5):498–504
Finstein JL, King JJ, Fox EJ, Ogilvie CM, Lackman RD (2007) Bipolar proximal femoral replacement prostheses for musculoskeletal neoplasms. Clin Orthop Relat Res 459:66–75
Sarahrudi K, Greitbauer M, Platzer P, Hausmann JT, Heinz T, Vécsei V (2009) Surgical treatment of metastatic fractures of the femur: a retrospective analysis of 142 patients. J Trauma 66(4):1158–1163
Zacherl M, Gruber G, Glehr M, Ofner-Kopeinig P, Radl R, Greitbauer M, Vecsei V, Windhager R (2011) Surgery for pathological proximal femoral fractures, excluding femoral head and neck fractures: resection vs. stabilisation. Int Orthop 35(10):1537–1543
Manoso MW, Frassica DA, Lietman ES, Frassica FJ (2007) Proximal femoral replacement for metastatic bone disease. Orthopedics 30(5):384–388
Alvi HM, Damron TA (2013) Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone? Clin Orthop Relat Res 471(3):706–714
Mavrogenis AF, Pala E, Romagnoli C, Romantini M, Calabro T, Ruggieri P (2012) Survival analysis of patients with femoral metastases. J Surg Oncol 105(2):135–141
Willeumier JJ, van der Linden YM, van de Sande MAJ, Dijkstra PDS (2016) Treatment of pathological fractures of the long bones. EFORT Open Rev 1:136–145
Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 26(3):298–306
Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 30(19):2186–2191
Bauer HC, Wedin R (1995) Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 66(2):143–146
Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE (2006) Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 24(21):3388–3393
van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group (2005) Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103(2):320–328
Mizumoto M, Harada H, Asakura H, Hashimoto T, Furutani K, Hashii H, Takagi T, Katagiri H, Takahashi M, Nishimura T (2008) Prognostic factors and a scoring system for survival after radiotherapy for metastases to the spinal column: a review of 544 patients at Shizuoka Cancer Center Hospital. Cancer 113(10):2816–2822
Lipton A, Fizazi K, Stopeck AT, Henry DH, Brown JE, Yardley DA, Richardson GE, Siena S, Maroto P, Clemens M, Bilynskyy B, Charu V, Beuzeboc P, Rader M, Viniegra M, Saad F, Ke C, Braun A, Jun S (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48(16):3082–3092
Katagiri H, Okada R, Takagi T, Takahashi M, Murata H, Harada H, Nishimura T, Asakura H, Ogawa H (2014) New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med 3(5):1359–1367
Acknowledgments
The authors thank Cristina Ghinelli, medical illustrator, for the design of the figures for this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Errani, C., Mavrogenis, A.F., Cevolani, L. et al. Treatment for long bone metastases based on a systematic literature review. Eur J Orthop Surg Traumatol 27, 205–211 (2017). https://doi.org/10.1007/s00590-016-1857-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-016-1857-9